𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Number of pregnancies and ovariectomy modify mammary carcinoma development in transgenic HER-2/neu female mice

✍ Scribed by Vladimir N. Anisimov; Irina G. Popovich; Irina N. Alimova; Mark A. Zabezhinski; Anna V. Semenchenko; Anatoli I. Yashin

Book ID
117467680
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
153 KB
Volume
193
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of melatonin treatment regime
The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice
✍ Vladimir N. Anisimov; Irina N. Alimova; Dmitri A. Baturin; Irina G. Popovich; Ma πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 138 KB πŸ‘ 1 views

## Abstract The effect of various regimens of treatment with melatonin on the development of mammary tumors in HER2/neu transgenic mice was investigated. Female HER‐2/neu mice starting from the age of 2 months were kept under standard light/dark regimen and as given melatonin with tap water (20 mg/

Down regulation of major histocompatibil
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice
✍ Pier-Luigi Lollini; Giordano Nicoletti; Lorena Landuzzi; Carla De Giovanni; Ilar πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 205 KB πŸ‘ 2 views

Transgenic mice carrying the HER-2/neu proto-oncogene under tissue-specific transcriptional control of a mammary tumor virus long terminal repeat (Tg-MMTVneu mice) spontaneously develop mammary carcinomas. HER-2/neu is a tumor antigen that can be recognized by cytotoxic T lymphocytes if tumor cells

Inhibitory effect of the peptide epitalo
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
✍ Vladimir N. Anisimov; Vladimir KH. Khavinson; Mauro Provinciali; Irina N. Alimov πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 133 KB πŸ‘ 2 views

Female FVB/N HER-2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon(R) (Ala-Glu-Asp-Gly) or with the peptide Vilon(R) (Lys-Glu) in a single dose of 1 microg/mouse for 5 consecutive days every month. Epitalon treatment reduced the cumulative